drugset / Trial / NCT02408393

MIRs03: Paravertebral Block With Ropivacaine Before Breast Cancer Surgery

NCT02408393

Phase 3 Completed 380 enrolled Institut Curie
RandomizedParallel-groupDouble-blindTreatment

Summary

Compare the effect of paravertebral block (PVB) with Ropivacaine or placebo on the incidence of chronic pain 3 months after breast cancer surgery.

Timeline

Start
2015-03-27
Primary completion
2018-07
Completion
2019-03-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Ropivacaine Other / unclassified 7.5 mg/ml Other

Indications